发明名称 Solid dose form of nanoparticulate naproxen
摘要 Described are solid dose nanoparticulate naproxen formulations having high rates of dissolution. The solid dose nanoparticulate naproxen formulations can comprise an alkali compound, which functions to increase the dissolution rate of the naproxen following administration. Alternatively, the solid dose nanoparticulate naproxen formulation can comprise an alkali compound and an acidic compound, which can react together to form carbon dioxide. The formed carbon dioxide can also aid in increasing the dissolution rate of the naproxen following administration. Also described are solid dose nanoparticulate naproxen formulations having a decreased concentration of a binder/disintegrant agent. Such compositions also provide an increased rate of dissolution of naproxen following administration.
申请公布号 US6165506(A) 申请公布日期 2000.12.26
申请号 US19980148332 申请日期 1998.09.04
申请人 ELAN PHARMA INTERNATIONAL LTD. 发明人 JAIN, RAJEEV A.;WEI, LINDEN;SWANSON, JON
分类号 A61K9/51;A61K9/14;A61K9/20;A61K9/46;A61K31/192;A61K47/04;A61K47/12;A61K47/14;A61K47/20;A61K47/22;A61K47/26;A61K47/34;A61P25/04;A61P29/00;(IPC1-7):A61K9/46;A01N37/10;A61L9/04 主分类号 A61K9/51
代理机构 代理人
主权项
地址